Correction: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study

Correction: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study

Saved in:

Bibliographic Details
Main Authors:	Matthew Anson, Jun Shang Poon, Alex E. Henney, David Riley, Gema H. Ibarbaru, Cyril Sieberhagen, Daniel J. Cuthbertson, Uazman Alam, Theresa Hydes
Format:	Article
Language:	English
Published:	BMC 2025-03-01
Series:	BMC Medicine
Online Access:	https://doi.org/10.1186/s12916-025-04033-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study
by: Matthew Anson, et al.
Published: (2024-12-01)

Current Management of Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Benny Budiman
Published: (2024-05-01)

Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
by: Suneth Buddhika Agampodi, et al.
Published: (2022-11-01)

Therapeutic potential of Medical Nutrition Therapy (MNT) in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Abdul-Malik Bawah, et al.
Published: (2025-06-01)

Diet and Non-Alcoholic Fatty Liver Disease (NAFLD): Advances and Management Strtegies : A Comprehensive Review
by: Syeda Farha S, et al.
Published: (2025-06-01)

The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD).
by: Roberta D'Ambrosio, et al.
Published: (2021-01-01)

Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD): Trends, Mortality, and Socioeconomic Disparities in the U.S., 1998–2020
by: Paul Wasuwanich, et al.
Published: (2025-01-01)

Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes
by: Tom Luedde, et al.
Published: (2021-03-01)

Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
by: Osama Hamdy, et al.
Published: (2021-10-01)

Effect of water extract of bay laurel (Laurus nobilis L.) on non-alcoholic fatty liver disease (NAFLD)
by: Minhee Lee, et al.
Published: (2025-04-01)

Treating Type 2 Diabetes With Early, Intensive, Multimodal Pharmacotherapy: Real-World Evidence From an International Collaborative Database
by: Matthew Anson, et al.
Published: (2024-01-01)

Global research trends in Chinese medicine for the treatment of non-alcoholic fatty liver disease (NAFLD): A bibliometric study
by: Kangjie li, et al.
Published: (2025-03-01)

Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
by: Atul Goyale, et al.
Published: (2021-01-01)

Study of Prevalence of Non-Alcoholic Fatty Liver Disease in Hypothyroidism and Possible Association of Hypothyroidism with NAFLD Fibrosis Score in Odisha
by: Siba Prasad Dalai, et al.
Published: (2024-07-01)

Correlation of Short Chain Fatty Acid (SCFA) Levels with Transient Elastography Values and Controlled Attenuation Parameters in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Desi Astari, et al.
Published: (2025-07-01)

A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity
by: Jie Chen, et al.
Published: (2023-10-01)

Parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: outcomes from LOCATE-NAFLD
by: Sanjeewa Kularatna, et al.
Published: (2024-12-01)

Impact of Black Pepper (Piper nigrum) Powder on Lipid Profile Parameters Among Subjects with Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Beenish, et al.
Published: (2025-01-01)

Chemoprotection and Immunostimulation of Alpha-Lipoic Acid Against Chlorpyrifos-Induced Toxicosis in Nile Tilapia, Oreochromis niloticus
by: Bilal A. Paray, et al.
Published: (2025-01-01)

Possible Role of Platelets in the Development and Progression of Non-Alcoholic Fatty Liver Disease
by: Anna F. Sheptulina, et al.
Published: (2025-03-01)

Transitioning from NAFLD to MAFLD and MASLD: the toxic relationship with alcohol consumption
by: Mubin Ozercan, et al.
Published: (2025-01-01)

Tocotrienol-rich fraction in medium-chain triglyceride carrier upregulates purine metabolism in non-alcoholic fatty liver disease (NAFLD) animal model
by: Mohd Danial Mohd Efendy Goon, et al.
Published: (2025-04-01)

The impact of serum neuregulin 4 (NRG-4) levels on non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
by: Mohammad Amin Tapak, et al.
Published: (2025-07-01)

Effects of Time-Restricted Hypocaloric Mediterranean Diet in Patients with Non-Alcoholic Fatty Liver Disease: Preliminary Data from the CHRONO-NAFLD Project
by: Sofia Tsitsou, et al.
Published: (2024-02-01)

Non-alcoholic fatty liver disease (NAFLD): A comparative study of clinico-socio-demographic characteristics among two diverse Indian population
by: Prangya Paramita Sahoo, et al.
Published: (2024-09-01)

Chemoprotection of amazonian Mauritia flexuosa fruit pulp against ammonia and nitrite toxicity to postlarvae shrimps Litopenaeus vannamei
by: Cleber dos Santos SIMIÃO, et al.
Published: (2022-05-01)

Chemoprotection of amazonian Mauritia flexuosa fruit pulp against ammonia and nitrite toxicity to postlarvae shrimps Litopenaeus vannamei
by: Cleber dos Santos Simião, et al.
Published: (2022-05-01)

High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study
by: Ashim Das, et al.
Published: (2019-08-01)

Growing Epidemic of Nonalcoholic Fatty Liver Disease (NAFLD) in India: Time to Revisit the Diet
by: Sharmila Dudani, et al.
Published: (2023-06-01)

Mean platelet volume as a biomarker for liver fibrosis in patients with Non-alcoholic fatty liver disease.
by: Eun Hye Cho, et al.
Published: (2025-01-01)

Effects of hormone replacement therapy (HRT) in midlife women with type 2 diabetes: a retrospective cohort study
by: Matthew Anson, et al.
Published: (2025-07-01)

StackNAFLD: An Accurate Stacking Ensemble Learning Targeting NAFLD Treatment
by: Andi Endang Kusuma Intan, et al.
Published: (2025-08-01)

Development and validation of a nomogram-based risk prediction model for non-alcoholic fatty liver disease (NAFLD): a logistic regression analysis in a physical examination population
by: Jing Lan, et al.
Published: (2025-07-01)

Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
by: Helen Jarvis, et al.
Published: (2020-04-01)

T-HAD Score: A Novel Diagnostic Model for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD)
by: Tharun Tom Oommen, et al.
Published: (2023-01-01)

Effects of Aramchol in patients with nonalcoholic fatty liver disease (NAFLD). A systematic review and meta-analysis
by: Adnan Malik, et al.
Published: (2022-02-01)

From NAFLD to MASLD – a new approach for the definition of fatty liver disease associated with metabolic dysfunction
by: Iwona Gorczyca-Głowacka, et al.
Published: (2025-01-01)

High-starchy carbohydrate diet aggravates NAFLD by increasing fatty acids influx mediated by NOX2
by: Yuqi Gao, et al.
Published: (2023-07-01)

Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo)
by: Suneth Buddhika Agampodi, et al.
Published: (2022-10-01)

The role of C-reactive protein to lymphocyte ratio in NAFLD and mortality among NAFLD patients
by: Jianxin Xi, et al.
Published: (2025-05-01)